You are here: All Products  > Everest Approved to Launch ADC for Triple-Negative Breast Cancer in China

Everest Approved to Launch ADC for Triple-Negative Breast Cancer in China

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products